Ontrak, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OTRKQ research report →
Price Chart
About the company
Ontrak, Inc. is a virtualized healthcare company that leverages artificial intelligence and telehealth to deliver services, including in-person components, to health plans and other third-party payors across the United States. Its sophisticated, technology-driven platform can predict which individuals with chronic conditions are likely to benefit from behavioral modifications.
- CEO
- Brandon H. LaVerne
- IPO
- 2003
- Employees
- 104
- HQ
- Miami, FL, US
Get TickerSpark's AI analysis on OTRKQ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $708
- P/E
- -0.00
- Fwd P/E
- 0.00
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.12
- Div Yield
- 0.00%
- Gross Margin
- 62.92%
- Op Margin
- -161.35%
- Net Margin
- -235.01%
- ROE
- -211.17%
- ROIC
- -95.26%
Latest fiscal year · YoY change
- Revenue
- $10.85M-14.9%
- Gross Profit
- $6.82M-22.5%
- Op Income
- $-17,500,000
- Net Income
- $-25,489,000+8.7%
- EPS
- $-5.49+8.3%
- OCF Growth
- +13.3%
- FCF Growth
- +13.8%
- 52W High
- $0.09
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -6.84
- RSI (14)
- 52
- Avg Volume
- 1.40K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Ontrak said Q1 reflected lower revenue and gross margin from a lost customer and Engage mix shift, but member enrollment, pipeline momentum, and financing capacity all improved.· May 20, 2025
- Q1 revenue was $2 million, down 25% year over year, while gross margin fell to 37% from 63.6% last year.
- Total enrolled members reached 3,165 at quarter-end, nearly doubling year over year and the highest since Q4 2021.
- Management highlighted strong pipeline momentum, including a large Midwestern Medicaid plan with 300,000 members and four other proposals under review.
- Q2 revenue guidance is $2.2 million to $2.6 million, implying 8% to 22% sequential growth.
- The company ended Q1 with $4.1 million of cash and said it now has up to $10 million of additional financing available in the near term.
Ontrak reported Q1 2025 revenue of $2 million, down 25% year over year. Gross margin was 37%, versus 63.6% in Q1 2024 and 61% in Q4 2024. Cash flow from operations was negative $2.7 million, compared with negative $3.3 million a year ago and negative $4.3 million in Q4 2024. Quarter-end cash was $4.1 million, down from $5.7 million at the end of 2024. Enrolled members ended the quarter at 3,165, up from 2,125 at the start of the quarter, with 1,152 in Engage. For Q2 2025, management guided to revenue of $2.2 million to $2.6 million, or 8% to 22% sequential growth. Management also said current customers under contract account for approximately $14 million to $16 million of annual revenue, and if bottom-of-funnel opportunities are converted they could add approximately $15 million of revenue.
Brandon LaVerne framed Q1 as continued momentum from 2024, emphasizing that customer outreach is expanding, new implementations are underway, and total enrolled members nearly doubled year over year. He pointed to the Engage solution, provider-model strategy, and AI-enabled operational tools as evidence that Ontrak has broadened its market reach and improved productivity. His tone was optimistic, especially around the possibility that successful sales conversions could help double run-rate revenue in 2025 versus 2024.
James Park focused on the financial impact of the customer loss and the Engage mix shift, which reduced revenue per enrolled member to about $254 from $500 in Q4 2024 and $504 in Q1 2024. He noted that Q1 gross margin was 37% and said it should stay around current levels, then improve as a higher share of WholeHealth+ members comes through the funnel, though margins may dip during launch periods because the company staffs up ahead of expansions. On liquidity, he said cash flow from operations was negative $2.7 million, cash was $4.1 million at quarter end, and the company borrowed $1.5 million under its Keep Well agreement during the quarter plus another $0.5 million after quarter end; he also said an additional financing agreement provides up to $10 million more capital in the short term.
This was not a traditional Q&A-heavy call in the transcript provided. The key investor concerns were implicit in management’s discussion: how quickly the large Midwestern Medicaid opportunity and four other proposals convert, and whether margin pressure from new launches and the Engage mix shift can be offset by WholeHealth+ growth. Management answered by stressing that the pipeline is advanced, the Medicaid provider approvals are already in place for some prospects, and the company has financing flexibility to support growth.
The positive case is that enrollment momentum is real: total members hit 3,165, the highest since Q4 2021, and new enrollments were the strongest since Q3 2021. Management also sees multiple revenue expansion paths, including a large Medicaid plan opportunity and added financing capacity, while saying current contracts already represent $14 million to $16 million of annual revenue.
The main risks are that Q1 revenue fell 25% year over year and gross margin compressed sharply to 37% because of a lost customer and a lower-revenue Engage mix. Liquidity remains tight with $4.1 million of cash at quarter end, and the bullish revenue case depends heavily on converting a handful of large opportunities that are still in process.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 56.4%
- Shares Outstanding
- 7.08M
- Float Shares
- 4.00M
Buy/sell ratio 2.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 20, 25 | PEIZER TERREN S | other | 500,000 |
| Jun 20, 25 | PEIZER TERREN S | other | 500,000 |
| Jun 18, 25 | PEIZER TERREN S | other | 359,712 |
| Jun 18, 25 | PEIZER TERREN S | buy | 0 |
| Jun 14, 25 | Park James J | other | 4 |
| Jun 14, 25 | Park James J | other | 1 |
| Jun 14, 25 | Park James J | other | 4 |
| May 27, 25 | PEIZER TERREN S | other | 1,635,220 |
| May 27, 25 | PEIZER TERREN S | buy | 0 |
| May 9, 25 | PEIZER TERREN S | other | 609,756 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our OTRKQ coverage
Recent articles, reports, and earnings notes.
No research on OTRKQ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OTRKQ report →Will Ontrak, Inc. (OTRK) Report Negative Q2 Earnings? What You Should Know
zacks.com · Aug 7
Ontrak (OTRK) Upgraded to Buy: Here's Why
zacks.com · Jul 11
Here's Why Ontrak (OTRK) Could be Great Choice for a Bottom Fisher
zacks.com · Jul 11
Ontrak Health Announces Pricing of $4 Million Public Offering
businesswire.com · Jun 27
Ontrak Health Announces Expansion of Engage Solution for Sentara Health Plans Self-funded Employer Customers
businesswire.com · Jun 24
Ontrak, Inc. (OTRK) Q1 2025 Earnings Call Transcript
seekingalpha.com · May 20
Ontrak Health Announces 2025 First Quarter Financial Results
businesswire.com · May 20
Ontrak Secures Financing Commitment to Fuel Growth and Innovation
businesswire.com · May 20
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.